Current Rating and Its Significance
The 'Buy' rating assigned to Apollo Hospitals Enterprise Ltd. indicates a positive outlook on the stock’s potential for capital appreciation and overall financial health. This recommendation is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Investors should understand that this rating suggests the stock is expected to outperform the broader market or its sector peers over the medium term, making it a favourable addition to a diversified portfolio.
Quality Assessment
As of 25 June 2026, Apollo Hospitals demonstrates strong operational quality. The company boasts a high Return on Capital Employed (ROCE) of 17.13%, signalling efficient use of capital to generate profits. This level of management efficiency is a critical indicator of sustainable business performance. Furthermore, Apollo has maintained positive results for ten consecutive quarters, underscoring consistent operational strength and resilience in the hospital sector.
Valuation Perspective
The valuation of Apollo Hospitals is currently attractive relative to its historical averages and peer group. The stock trades at an Enterprise Value to Capital Employed (EV/CE) ratio of 8.2, which is considered reasonable given the company’s growth prospects. Additionally, the PEG ratio stands at 1.8, reflecting a balanced relationship between price, earnings, and growth expectations. This valuation suggests that the stock is not overextended and offers a compelling entry point for investors seeking value within the healthcare sector.
Financial Trend and Growth Metrics
The latest data as of 25 June 2026 reveals robust financial trends for Apollo Hospitals. Net sales have grown at an annualised rate of 19.03%, while operating profit has surged by 38.67% annually, highlighting strong margin expansion. The company’s quarterly net sales reached a record high of ₹6,605.50 crores, with PBDIT also hitting a peak of ₹1,011.00 crores. These figures reflect healthy demand and operational leverage, supporting the positive financial grade assigned to the stock.
Technical Analysis
From a technical standpoint, Apollo Hospitals exhibits bullish momentum. The stock has delivered a 21.34% return over the past year and a 21.40% gain year-to-date, outperforming many large-cap peers in the hospital sector. Short-term price movements show modest volatility, with a 1-day decline of 0.27% offset by gains of 1.64% over one week and 12.77% over three months. This technical strength complements the fundamental outlook, reinforcing the 'Buy' rating.
Institutional Confidence
Institutional investors hold a significant 65.61% stake in Apollo Hospitals, indicating strong confidence from knowledgeable market participants. Such holdings often reflect thorough fundamental analysis and long-term commitment, which can provide stability to the stock price and reduce downside risk for retail investors.
Summary of Key Financial and Market Metrics
As of 25 June 2026, Apollo Hospitals Enterprise Ltd. is classified as a large-cap stock within the hospital sector. The company’s Mojo Score stands at 78.0, reflecting a solid 'Buy' grade, up from a previous 'Hold' rating with a score of 68 as of 11 May 2026. This improvement in score underscores the enhanced confidence in the company’s prospects based on recent performance and valuation.
Our latest weekly pick is live! This Large Cap from Diamond & Gold Jewellery comes with clear entry and exit targets. See the detailed report with target price now!
- - Clear entry/exit targets
- - Target price revealed
- - Detailed report available
Implications for Investors
For investors considering Apollo Hospitals Enterprise Ltd., the current 'Buy' rating suggests that the stock offers a favourable risk-reward profile. The combination of strong quality metrics, attractive valuation, positive financial trends, and bullish technical signals provides a comprehensive foundation for potential capital appreciation. Investors should note that the rating reflects the company’s position as of 25 June 2026, ensuring decisions are based on the most recent data rather than historical snapshots.
Sector and Market Context
Within the hospital sector, Apollo Hospitals stands out as a leader with consistent growth and operational excellence. The healthcare industry continues to benefit from increasing demand for quality medical services, driven by demographic trends and rising health awareness. Apollo’s ability to sustain high returns and expand margins positions it well to capitalise on these sector tailwinds.
Stock Performance Overview
The stock’s performance over various time frames further supports the positive outlook. Over the past six months, Apollo Hospitals has gained 19.22%, while the year-to-date return is 21.40%. These returns are complemented by strong profit growth of 35.3% over the last year, indicating that earnings momentum is keeping pace with, or exceeding, price appreciation. This alignment is a positive sign for investors seeking growth stocks with solid fundamentals.
Conclusion
In summary, Apollo Hospitals Enterprise Ltd. is currently rated 'Buy' by MarketsMOJO, reflecting a well-rounded assessment of quality, valuation, financial health, and technical strength. The rating was last updated on 11 May 2026, but the detailed analysis and data presented here are current as of 25 June 2026, providing investors with an up-to-date perspective. Given the company’s strong management efficiency, attractive valuation metrics, robust financial trends, and positive market sentiment, the stock remains a compelling option for investors seeking exposure to the hospital sector’s growth potential.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
